Value based healthcare for rare diseases: efficiency, efficacy, equity

Area of Science:

• Health Economics
• Public Health Policy
• Rare Disease Management

Background:

• Value-based healthcare (VBHC) traditionally focuses on economic efficiency and clinical outcomes.
• Defining value in healthcare requires considering economic, cultural, and equity dimensions.
• Rare diseases present unique challenges to standard healthcare evaluation methods.

Purpose of the Study:

• To review the literature on value-based healthcare and its applicability to rare diseases.
• To explore the economic and cultural factors influencing VBHC in the context of rare conditions.
• To identify barriers and propose alternative strategies for rare disease healthcare delivery.

Main Methods:

• Literature review of value-based healthcare principles and their application to rare diseases.
• Analysis of economic definitions of value, healthcare evaluation, efficacy, and efficiency.
• Inclusion of equity and cultural frameworks in defining value-based healthcare.

Main Results:

• The applicability of value-based healthcare to rare diseases is limited by prevention/recovery views and global cost-benefit evaluations.
• Epidemiological challenges in rare diseases hinder the implementation of value-based public health strategies.
• A narrow focus on traditional economic metrics inadequately captures the value of care for rare conditions.

Conclusions:

• A paradigm shift towards a new culture of health and well-being is necessary for rare diseases.
• Re-evaluation of healthcare service organization, prevention delivery, and patient empowerment is crucial.
• Alternative strategies are needed to support vulnerable and marginalized groups affected by rare diseases.